Ichinomiya, Japan

Mitsuru Mizuno


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Mitsuru Mizuno: Innovator in Benzimidazole Stabilization**

Introduction

Mitsuru Mizuno is a prominent inventor based in Ichinomiya, Japan, known for his critical contributions to the pharmaceutical industry. With a focus on the stabilization of benzimidazole compounds, he has made significant advancements that have implications for oral solid formulations.

Latest Patents

Mitsuru Mizuno holds one notable patent titled "Methods for Stabilizing Benzimidazole Compounds." This patent outlines a method for stabilizing an oral solid formulation that contains a benzimidazole-based compound or its physiologically acceptable salt. Specifically, it describes the incorporation of crospovidone and sodium or potassium hydroxide into the formulation, enhancing the stability and efficacy of these compounds in medical applications.

Career Highlights

Mizuno is currently associated with Eisai R&D Management Co., Ltd., where he continues to innovate and contribute to the company's ongoing research and development efforts. His work at this esteemed organization reflects his commitment to advancing pharmaceutical formulations that benefit patients worldwide.

Collaborations

Throughout his career, Mitsuru Mizuno has collaborated with various esteemed professionals, including colleagues Koji Ukai and Satoshi Fujioka. These partnerships highlight the importance of teamwork and collective expertise in the pursuit of groundbreaking innovations in the pharmaceutical field.

Conclusion

Mitsuru Mizuno's remarkable contributions to the stabilization of benzimidazole compounds reflect his dedication to innovation and improvement in pharmaceutical formulations. As he continues to work with Eisai R&D Management Co., Ltd. and collaborate with fellow researchers, his impact on the industry is likely to grow, enhancing the efficacy of medication available to patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…